Chronic risperidone normalizes elevated pro-inflammatory cytokine and C-reactive protein production in omega-3 fatty acid deficient rats

European Journal of Pharmacology

Volumn 652, Issue 1-3, 2011, Pages 152-156

  McNamara, Robert K ^a   Jandacek, Ronald ^a   Rider, Therese ^a   Tso, Patrick ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Antipsychotic; Arachidonic acid; C reactive protein; Cytokine; Docosahexaenoic acid; Eicosapentaenoic acid; Erythrocyte; Inflammation; Interleukin 6; Rat; Risperidone; Tumor necrosis factor alpha

Indexed keywords

ADRENIC ACID; ARACHIDONIC ACID; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; OMEGA 3 FATTY ACID; RISPERIDONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ERYTHROCYTE LEVEL; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID SYNTHESIS; LIPID COMPOSITION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SIGNAL TRANSDUCTION; TREATMENT DURATION;

ANIMALS; ANTIPSYCHOTIC AGENTS; C-REACTIVE PROTEIN; CHRONIC DISEASE; CYTOKINES; DIET, FAT-RESTRICTED; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; INFLAMMATION; MALE; RATS; RATS, LONG-EVANS; RISPERIDONE;

EID: 78650920485     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.11.010     Document Type: Article

References (20)

1. S. Akhondzadeh, M. Tabatabaee, H. Amini, S.A. Ahmadi Abhari, S.H. Abbasi, and B. Behnam Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial Schizophr. Res. 90 2007 179 185 (Pubitemid 46177578)
2. Q. Bian, T. Kato, A. Monji, S. Hashioka, Y. Mizoguchi, H. Horikawa, and S. Kanba The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 42 48
3. P.C. Calder The relationship between the fatty acid composition of immune cells and their function Prostaglandins Leukot. Essent. Fatty Acids 79 2008 101 108
4. R.C. Drexhage, E.M. Knijff, R.C. Padmos, L. Heul-Nieuwenhuijzen, W. Beumer, M.A. Versnel, and H.A. Drexhage The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder Expert Rev. Neurother. 10 2010 59 76
5. L. Drzyzga, E. Obuchowicz, A. Marcinowska, and Z.S. Herman Cytokines in schizophrenia and the effects of antipsychotic drugs Brain Behav. Immun. 20 2006 532 545
6. A.L. Groeger, C. Cipollina, M.P. Cole, S.R. Woodcock, G. Bonacci, T.K. Rudolph, V. Rudolph, B.A. Freeman, and F.J. Schopfer Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids Nat. Chem. Biol. 6 2010 433 441
7. M. Igarashi, K. Ma, L. Chang, J.M. Bell, and S.I. Rapoport Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain J. Lipid Res. 48 2007 2463 2470
8. T. Kato, A. Monji, S. Hashioka, and S. Kanba Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro Schizophr. Res. 92 2007 108 115
9. B. Khalfoun, F. Thibault, H. Watier, P. Bardos, and Y. Lebranchu Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6 Adv. Exp. Med. Biol. 400 1997 589 597
10. D.Y. Lu, Y.Y. Tsao, Y.M. Leung, and K.P. Su Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids Neuropsychopharmacology 35 2010 2238 2248
11. R.K. McNamara Modulation of polyunsaturated fatty acid biosynthesis by antipsychotic medications: implications for the pathophysiology and treatment of schizophrenia Clin. Lipidol. 4 2009 809 820
12. R.K. McNamara, J. Sullivan, and N.M. Richtand Omega-3 fatty acid deficiency augments the development of behavioral sensitization in adult mice: prevention by chronic lithium treatment J. Psychiatr. Res. 42 2008 458 468
13. R.K. McNamara, J.A. Able, R. Jandacek, T. Rider, and P. Tso Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: evidence for augmented biosynthesis Schizophr. Res. 107 2009 150 157
14. McNamara R.K., Rider T., Jandacek R., Tso P., Straus A., and Lipton J.W. Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover Prostaglandins Leukot. Essent. Fatty Acids 83 2010 185 191
15. R. Mingam, A. Moranis, R.M. Bluthé, V. De Smedt-Peyrusse, K.W. Kelley, P. Guesnet, M. Lavialle, R. Dantzer, and S. Layé Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice Eur. J. Neurosci. 28 2008 1877 1886
16. J.P. Portanova, Y. Zhang, G.D. Anderson, S.D. Hauser, J.L. Masferrer, K. Seibert, S.A. Gregory, and P.C. Isakson Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo J. Exp. Med. 184 1996 883 891
17. C.N. Serhan Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins Curr. Opin. Clin. Nutr. Metab. Care 8 2005 115 121
18. H. Sugino, T. Futamura, Y. Mitsumoto, K. Maeda, and Y. Marunaka Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 303 307
19. P. Wang, F. Zhu, and K. Konstantopoulos Prostaglandin E2 induces interleukin-6 expression in human chondrocytes via cAMP/protein kinase A- and phosphatidylinositol 3-kinase-dependent NF-kappaB activation Am. J. Physiol. Cell Physiol. 298 2010 1445 1456
20. Y. Watanabe, T. Someya, and H. Nawa Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models Psychiatry Clin. Neurosci. 64 2010 217 230